| Front Page |
|
Mascola Named VRC Deputy Director
"John Mascola has been a major contributor to HIV vaccine development through his studies on neutralizing antibodies. His thoughtful, scholarly work on their role in neutralization in vitro and in non-human primate models has led to a better understanding of protective immunity," added Nabel. Mascola will oversee the biosafety level-3 facility in its basic and applied research activities, and promote programs that meet the VRC's scientific objectives. He will also represent the VRC at NIH planning and advisory meetings, and at national and international conferences and workshops. He currently holds two positions in the division of retroviology at Walter Reed Army Institute of Research, including head of the department of HIV prevention research and assistant head of the department of HIV vaccine development. He also held concurrent appointments of associate professor of medicine at the Uniformed Services University of the Health Sciences and research physician at the Naval Medical Research Institute. Mascola is a fellow of the American College of Physicians, and a member of the Infectious Diseases Society of America and the American Assocation for the Advancement of Science. Ganson Is New NIDCR Planning Officer
Roederer Directs Flow Cytometry at VRC
"Mario has made important contributions to understanding the pathogenesis of HIV infection through careful studies of lymphocyte subsets. His expertise in human immunology and flow cytometry will provide a sound foundation for understanding immune responses to vaccines in humans and animal models," said Dr. Gary Nabel, VRC director. Roederer will also continue his research into the function of the human immune system during disease. His research will focus on four primary areas: isolation and functional characterization of T cell subsets, the role of these subsets in supporting HIV infection, molecular and cellular biology of antigen-specific immunity, and immune responses at mucosal surfaces. Information obtained from these studies will be essential for evaluating potential HIV treatment and prevention strategies, especially HIV vaccines. Roederer received his Ph.D. in biological sciences from Carnegie Mellon University and conducted postdoctoral research in immunology at Stanford University. He comes to the VRC from the University of California, San Francisco, where he was an adjunct associate professor in the department of stomatology. Monsees Directs OPEC at CIT
Up to Top |